TY - JOUR
T1 - Increased transvascular lipoprotein transport in diabetes
T2 - Association with albuminuria and systolic hypertension
AU - Jensen, Jan Skov
AU - Feldt-Rasmussen, Bo
AU - Borch-Johnsen, Knut
AU - Jensen, Kurt Svarre
AU - Nordestgaard, Børge Grønne
PY - 2005/8/1
Y1 - 2005/8/1
N2 - Context: Diabetes is associated with a highly increased risk of atherosclerosis, especially if hypertension or albuminuria is present. Objective: We hypothesized that the increased transvascular lipoprotein transport in diabetes may be further accelerated if hypertension or albuminuria is present, possibly explaining increased intimal lipoprotein accumulation and thus atherosclerosis. Design: The study was cross-sectional and was performed in 1999-2002. Setting: The study took place in the referral center. Patients: The patients included 60 with diabetes mellitus (27 with type 1 diabetes and 33 with type 2 diabetes) and 42 healthy controls. All were randomly recruited. Main Outcome Measure: We used an in vivo method for measurement of transvascular transport of low-density lipoprotein (LDL). Autologous 131I-LDL was reinjected iv, and the 1-h fractional escape rate was taken as an index of transvascular transport. Results: Transvascular LDL transport was 1.8 (1.6 -2.0), 2.3 (2.0-2.6), and 2.6 (1.3-4.0)%/[h × (liter/m2)] in healthy controls, diabetic controls, and diabetes patients with systolic hypertension or albuminuria, respectively (P = 0.013; F = 4.5; df =2; ANOVA). These differences most likely were not caused by altered hepatic LDL receptor expression, glycosylation of LDL, small LDL size, or medicine use. Conclusions: Transvascular LDL transport is increased in patients with diabetes mellitus, especially if systolic hypertension or albuminuria is present. Accordingly, lipoprotein flux into the arterial wall could be increased in these patients, possibly explaining accelerated development of atherosclerosis.
AB - Context: Diabetes is associated with a highly increased risk of atherosclerosis, especially if hypertension or albuminuria is present. Objective: We hypothesized that the increased transvascular lipoprotein transport in diabetes may be further accelerated if hypertension or albuminuria is present, possibly explaining increased intimal lipoprotein accumulation and thus atherosclerosis. Design: The study was cross-sectional and was performed in 1999-2002. Setting: The study took place in the referral center. Patients: The patients included 60 with diabetes mellitus (27 with type 1 diabetes and 33 with type 2 diabetes) and 42 healthy controls. All were randomly recruited. Main Outcome Measure: We used an in vivo method for measurement of transvascular transport of low-density lipoprotein (LDL). Autologous 131I-LDL was reinjected iv, and the 1-h fractional escape rate was taken as an index of transvascular transport. Results: Transvascular LDL transport was 1.8 (1.6 -2.0), 2.3 (2.0-2.6), and 2.6 (1.3-4.0)%/[h × (liter/m2)] in healthy controls, diabetic controls, and diabetes patients with systolic hypertension or albuminuria, respectively (P = 0.013; F = 4.5; df =2; ANOVA). These differences most likely were not caused by altered hepatic LDL receptor expression, glycosylation of LDL, small LDL size, or medicine use. Conclusions: Transvascular LDL transport is increased in patients with diabetes mellitus, especially if systolic hypertension or albuminuria is present. Accordingly, lipoprotein flux into the arterial wall could be increased in these patients, possibly explaining accelerated development of atherosclerosis.
UR - http://www.scopus.com/inward/record.url?scp=23844479558&partnerID=8YFLogxK
U2 - 10.1210/jc.2004-2420
DO - 10.1210/jc.2004-2420
M3 - Article
C2 - 15899947
AN - SCOPUS:23844479558
SN - 0021-972X
VL - 90
SP - 4441
EP - 4445
JO - Journal of Clinical Endocrinology and Metabolism
JF - Journal of Clinical Endocrinology and Metabolism
IS - 8
ER -